These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258 [TBL] [Abstract][Full Text] [Related]
4. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action. Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807 [TBL] [Abstract][Full Text] [Related]
5. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652. Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin. Scherer D; von Löwenstern K; Zitron E; Scholz EP; Bloehs R; Kathöfer S; Thomas D; Bauer A; Katus HA; Karle CA; Kiesecker C Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):73-83. PubMed ID: 18458880 [TBL] [Abstract][Full Text] [Related]
8. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate. Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655 [TBL] [Abstract][Full Text] [Related]
9. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration. Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Zitron E; Kiesecker C; Scholz E; Lück S; Bloehs R; Kathöfer S; Thomas D; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):146-56. PubMed ID: 15322737 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086 [TBL] [Abstract][Full Text] [Related]
12. Blockade of HERG human K+ channels by the antidepressant drug paroxetine. Lee SH; Sung MJ; Lee HM; Chu D; Hahn SJ; Jo SH; Choe H; Choi BH Biol Pharm Bull; 2014; 37(9):1495-504. PubMed ID: 25177033 [TBL] [Abstract][Full Text] [Related]
13. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues. Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083 [TBL] [Abstract][Full Text] [Related]
14. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel. Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046 [TBL] [Abstract][Full Text] [Related]
15. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels. Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158 [TBL] [Abstract][Full Text] [Related]
17. Effects of donepezil on hERG potassium channels. Chae YJ; Lee HJ; Jeon JH; Kim IB; Choi JS; Sung KW; Hahn SJ Brain Res; 2015 Feb; 1597():77-85. PubMed ID: 25498859 [TBL] [Abstract][Full Text] [Related]
18. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X). Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500 [TBL] [Abstract][Full Text] [Related]
19. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel. Jo SH; Hong HK; Chong SH; Choe H Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158 [TBL] [Abstract][Full Text] [Related]
20. Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656. Scholz EP; Konrad FM; Weiss DL; Zitron E; Kiesecker C; Bloehs R; Kulzer M; Thomas D; Kathöfer S; Bauer A; Maurer MH; Seemann G; Katus HA; Karle CA Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):275-84. PubMed ID: 17965852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]